NewsRelic Technologies Reports Q3FY26 Results with Mixed Standalone and Consolidated PerformanceRelic Technologies Reports Q3FY26 Results with Mixed Standalone and Consolidated Performance
Relic Technologies Limited reported Q3FY26 results showing a standalone net profit of ₹17.38 lakhs driven by other income, while consolidated operations posted a loss of ₹47.67 lakhs despite generating ₹32.16 lakhs in revenue. The company expanded its equity capital to ₹559.12 lakhs through warrant conversions and continues transitioning to pharma and wellness products, though regulatory approvals are still pending.
*this image is generated using AI for illustrative purposes only.
Relic Technologies Limited has released its unaudited financial results for the quarter and nine months ended December 31, 2025, revealing a stark contrast between its standalone and consolidated performance. The Mumbai-based company, which is transitioning its business activities to pharma and wellness products, demonstrated mixed operational outcomes during the reporting period.
Standalone Financial Performance
The company's standalone operations showed positive results for Q3FY26, despite the absence of operational revenue. Key financial metrics for the quarter demonstrate the company's reliance on non-operational income sources.
| Metric | Q3FY26 | Q3FY25 | Change |
|---|---|---|---|
| Revenue from Operations | - | ₹46.92 lakhs | - |
| Other Income | ₹35.04 lakhs | ₹2.91 lakhs | +1104.47% |
| Total Income | ₹35.04 lakhs | ₹49.83 lakhs | -29.67% |
| Net Profit/(Loss) | ₹17.38 lakhs | ₹(151.23) lakhs | Positive turnaround |
| Basic EPS | ₹0.34 | ₹(4.20) | Positive turnaround |
For the nine-month period ended December 31, 2025, standalone operations generated a net profit of ₹44.71 lakhs compared to a loss of ₹147.49 lakhs in the corresponding period of the previous year. The company maintained zero revenue from operations throughout the nine-month period, with total income of ₹92.76 lakhs coming entirely from other income sources.
Consolidated Results Show Operational Challenges
The consolidated financial results, which include subsidiaries Relic Pharma Ltd and Truhealthy Wellness Private Ltd, presented a different picture with operational revenue but significant losses.
| Metric | Q3FY26 | Q3FY25 | Change |
|---|---|---|---|
| Revenue from Operations | ₹32.16 lakhs | ₹46.92 lakhs | -31.43% |
| Total Income | ₹49.88 lakhs | ₹49.83 lakhs | +0.10% |
| Total Expenses | ₹206.04 lakhs | ₹149.65 lakhs | +37.70% |
| Net Loss | ₹(47.67) lakhs | ₹(99.82) lakhs | Reduced loss |
| Basic EPS | ₹(0.92) | ₹(2.77) | Improved |
The consolidated nine-month results showed a substantial net loss of ₹400.79 lakhs compared to ₹96.08 lakhs in the previous year. This significant increase in losses was attributed to higher operational expenses, particularly employee benefit expenses which rose to ₹333.38 lakhs from ₹22.73 lakhs in the corresponding period.
Capital Structure Enhancement
During Q3FY26, Relic Technologies strengthened its capital base through warrant conversions. The company successfully converted 4,41,164 warrants into equity shares following receipt of the balance 75% application money from warrant holders.
| Parameter | Details |
|---|---|
| Warrants Converted | 4,41,164 |
| Face Value per Share | ₹10 |
| Updated Paid-up Capital | ₹559.12 lakhs |
| Total Equity Shares | 55,91,640 |
This capital expansion increased the company's paid-up equity capital from ₹515.00 lakhs in the previous quarter to ₹559.12 lakhs as of December 31, 2025.
Business Transition Update
The company provided an important update regarding its strategic shift toward pharma and wellness products. Management disclosed that the planned change of activities to dealing in pharma and wellness products had not yet commenced revenue generation by December 31, 2025, as the company was still in the process of obtaining necessary regulatory permissions.
Subsidiary Performance Impact
The consolidated results were significantly influenced by subsidiary operations, with the two subsidiaries contributing ₹32.30 lakhs in revenue for the quarter and ₹220.48 lakhs for the nine-month period. However, these subsidiaries also reported substantial losses, with net loss before tax of ₹172.77 lakhs for the quarter and ₹414.32 lakhs for the nine-month period, highlighting operational challenges in the subsidiary businesses.
The financial results were approved by the Board of Directors in their meeting held on February 12, 2026, and have received unmodified review opinions from the company's statutory auditors, D. Kothary & Co., Chartered Accountants.
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
